Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: Findings from a large London case register

BMJ Open

Volumn 6, Issue 11, 2016, Pages

  Knapp, Martin ^a   Chua, Kia Chong ^b   Broadbent, Matthew ^c   Chang, Chin Kuo ^b   Fernandez, Jose Luis ^a   Milea, Dominique ^d   Romeo, Renee ^b   Lovestone, Simon ^e   Spencer, Michael ^f   Thompson, Gwilym ^f   Stewart, Robert ^b   Hayes, Richard D ^b  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^d H LUNDBECK A S   (Denmark)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f Janssen Cilag Ltd   (United Kingdom)

Author keywords

Alzheimer's disease; costs; hospital; nursing home

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; ENGLAND; FEMALE; HEALTH CARE COST; HOME CARE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PREDICTION; REGISTER; RESIDENTIAL CARE; SOCIAL ASPECT; VERY ELDERLY; AGE DISTRIBUTION; ECONOMICS; HOME FOR THE AGED; MENTAL HEALTH SERVICE; MIDDLE AGED; NURSING HOME; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEX RATIO; STATISTICAL MODEL;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; HOMES FOR THE AGED; HUMANS; LOGISTIC MODELS; LONDON; MALE; MENTAL HEALTH; MENTAL HEALTH SERVICES; MIDDLE AGED; NURSING HOMES; PATIENT ADMISSION; PSYCHIATRIC STATUS RATING SCALES; REGISTRIES; SEX DISTRIBUTION;

EID: 84996841724     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-013591     Document Type: Article

References (42)

1. Karlawish JH, Klocinski JL, Merz J, et al. Caregivers' preferences for the treatment of patients with Alzheimer's disease. Neurology 2000;55:1008-14.
2. Knapp M, Comas-Herrera A, Wittenberg R, et al. Scenarios of dementia care: what are the impacts on cost and quality of life? Discussion Paper 2878. PSSRU, London School of Economics and Political Science, 2014.
3. Prince M, Knapp M, Guerchet M, et al. Dementia UK. 2nd edn. London: Alzheimer's Society, 2014.
4. Luppa M, Luck T, Weyerer S, et al. Prediction of institutionalization in the elderly. A systematic review. Age Ageing 2010;39:31-8.
5. National Audit Office. Improving services and support for people with dementia. National Audit Office, 2007.
6. Yaffe K, Fox P, Newcomer R, et al. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 2002;287:2090-7.
7. Bond M, Rogers G, Peters J, et al. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess 2012;16:1-470.
8. Fernandes AC, Cloete D, Broadbent MT, et al. Development and evaluation of a de-identification procedure for a case register sourced from mental health electronic records. BMC Med Inform Decis Mak 2013;13:71.
9. Stewart R, Soremekun M, Perera G, et al. The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry 2009;9:51.
10. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
11. Cunningham H, Tablan V, Roberts A, et al. Getting more out of biomedical documents with GATE's full lifecycle open source text analytics. PLoS Comput Biol 2013;9:e1002854.
12. Sultana J, Chang CK, Hayes RD, et al. Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. Int J Geriatr Psychiatry 2014;29: 1249-54.
13. Chang CK, Hayes RD, Broadbent M, et al. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 2010;10:77.
14. Perera G, Khondoker M, Broadbent M, et al. Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health case register in London. PLoS ONE 2014;9:e109484.
15. Perera G, Broadbent M, Callard F, et al. Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record derived data resource. BMJ Open 2016;6:e008721.
16. Wing JK, Beevor AS, Curtis RH. Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry 1998;172:11-18.
17. Orrell M, Yard P, Handysides J, et al. Validity and reliability of the health of the nation outcome scales in psychiatric patients in the community. Br J Psychiatry 1999;174:409-12.
18. Pirkis JE, Burgess PM, Kirk PK, et al. A review of the psychometric properties of the Health of the Nation Outcome Scales (HoNOS) family of measures. Health Qual Life Outcomes 2005;3:76.
19. Hunter R, Cameron R, Norrie J. Using patient-reported outcomes in schizophrenia: the Scottish Schizophrenia Outcomes Study. Psychiatr Serv 2009;60:240-5.
20. Curtis L. Unit Costs of Health and Social Care 2011: Personal Social Services Research Unit, 2011. http://www.pssru.ac.uk/project-pages/unit-costs/2011/
21. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ 2004;23:525-42.
22. Manning WG, Morris CN, Newhouse JP, et al. A two-part model of the demand for medical care: preliminary results from the Health Insurance Study. In: van der Gaag J, Perlman M, eds. Health, economics and health economics. Amsterdam: North-Holland, 1981:103-23.
23. Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ 1998;17:247-81.
24. Park RE. Estimation with heteroscedastic error terms. Econometrica 1966;34:888.
25. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461-94.
26. Cameron A, Trivedi P. Nonlinear regression methods. Microeconometrics Using Stata. 2nd rev edn. Stata Press, 2010.
27. Bartus T. Estimation of marginal effects using margeff. Stata J 2005;5:309-29.
28. Department of Health. Living Well With Dementia: a national dementia strategy London, UK: Department of Health, 2009. https://www.gov.uk/government/publications/living-well-with-dementia-anational-dementia-strategy
29. Department of Health. Prime Minister's challenge on dementia-Delivering major improvements in dementia care and research by 2015 London, UK: Department of Health, 2012. https://www.gov.uk/government/publications/prime-ministers-challenge-ondementia
30. Department of Health. Prime Minister's challenge on dementia 2020 London, UK: Department of Health, 2015. https://www.gov.uk/government/publications/prime-ministers-challenge-on-dementia
31. Hebért R, Dubois MF, Wolfson C, et al. Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. J Gerontol A Med Sci 2001;56:M693-M99.
32. Stewart R, Hotopf M, Dewey M, et al. Current prevalence of dementia, depression and behavioural problems in the older adult care home sector: the South East London Care Home Survey. Age Ageing 2014;43:562-7.
33. Netten A, Darton R, Bebbington A, et al. Residential and nursing home care of elderly people with cognitive impairment: prevalence, mortality and costs. Aging Ment Health 2001;5:14-22.
34. Gaugler JE, Duval S, Anderson KA, et al. Predicting nursing home admission in the U.S: a meta-analysis. BMC Geriatr 2007;7:13.
35. Howard R, McShane R, Lindesay J, et al. Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses. Lancet Neurol 2015;14:1171-81.
36. Toot S, Devine M, Akporobaro A, et al. Causes of hospital admission for people with dementia: a systematic review and meta-analysis. J Am Med Dir Assoc 2013;14:463-70.
37. Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 2012;366:893-903.
38. Orrell M, Aguirre E, Spector A, et al. Maintenance cognitive stimulation therapy for dementia: single-blind, multicentre, pragmatic randomised controlled trial. Br J Psychiatry 2014;204: 454-61.
39. Wübker A, Zwakhalen SM, Challis D, et al. Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries. Eur J Health Econ 2015;16:689-707.
40. Livingston G, Kelly L, Lewis-Holmes E, et al. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technol Assess 2014;18:1-226.
41. Romeo R, Knapp M, Hellier J, et al. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. Br J Psychiatry 2013;202:121-8.
42. Davies B, Fernández J-L. The contribution of community-based health and social care to inpatient hospital use London, UK: LSE Health and Social Care, London School of Economics and Political Science, 2005. http://eprints.lse.ac.uk/13840/